Ariad leukemia drug helps 47 percent of patient: study (Reuters)
Reuters – Early results from a pivotal trial of Ariad Pharmaceuticals Inc’s experimental leukemia drug ponatinib show it is effective in nearly half of patients who had stopped responding to currently available drugs.
View full post on Yahoo! News: Health News
Leave a Reply